I．StageII，III大腸癌に対する術後補助化学療法

Y. Hashiguchi, K. Hase, K. Kotake, H. Ueno, E. Shinto, H. Mochizuki, J. Yamamoto, K. Sugihara, Evaluation of the seventh edition of the tumour, node, metastasis (TNM) classification for colon cancer in two nationwide registries of the United States and Japan Colorectal Disease. ,vol. 14, pp. 1065- 1074 ,(2012) , 10.1111/J.1463-1318.2011.02917.X

S. Sadahiro, T. Tsuchiya, K. Sasaki, K. Kondo, K. Katsumata, G. Nishimura, Y. Kakeji, H. Baba, S. Sato, K. Koda, Y. Yamaguchi, T. Morita, J. Matsuoka, H. Usuki, C. Hamada, S. Kodaira, Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502 Annals of Oncology. ,vol. 26, pp. 2274- 2280 ,(2015) , 10.1093/ANNONC/MDV358

G Peach, C Kim, E Zacharakis, S Purkayastha, P Ziprin, Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review British Journal of Cancer. ,vol. 102, pp. 1327- 1334 ,(2010) , 10.1038/SJ.BJC.6605651

James J. Biagi, Michael J. Raphael, William J. Mackillop, Weidong Kong, Will D. King, Christopher M. Booth, Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. ,vol. 305, pp. 2335- 2342 ,(2011) , 10.1001/JAMA.2011.749

Hans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, Marek P. Nowacki, Arie Figer, Jean Maroun, Timothy Price, Robert Lim, Eric Van Cutsem, Young-Suk Park, Joseph McKendrick, Claire Topham, Gemma Soler-Gonzalez, Filipo de Braud, Mark Hill, Florin Sirzén, Daniel G. Haller, Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients Journal of Clinical Oncology. ,vol. 26, pp. 102- 109 ,(2007) , 10.1200/JCO.2006.08.1075

Po-Huang LEE, Young-Suk PARK, Jia-Fu JI, Yiu-Tung FU, Vorachai RATANATHARATHORN, Safety and tolerability of FOLFOX4 in the adjuvant treatment of colon cancer in Asian patients: The MASCOT study Asia-pacific Journal of Clinical Oncology. ,vol. 5, pp. 101- 110 ,(2009) , 10.1111/J.1743-7563.2009.01199.X

Christophe Tournigand, Thierry André, Franck Bonnetain, Benoist Chibaudel, Gérard Lledo, Tamas Hickish, Josep Tabernero, Corrado Boni, Jean-Baptiste Bachet, Luis Teixeira, Aimery de Gramont, None, Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial Journal of Clinical Oncology. ,vol. 30, pp. 3353- 3360 ,(2012) , 10.1200/JCO.2012.42.5645

Peng Gao, Yong-xi Song, Zhen-ning Wang, Ying-ying Xu, Lin-lin Tong, Jing-xu Sun, Miao Yu, Hui-mian Xu, Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveilla006Ece, epidemiology, and end results (SEER) database BMC Cancer. ,vol. 13, pp. 123- 123 ,(2013) , 10.1186/1471-2407-13-123

Yasuhiro Shimada, Tetsuya Hamaguchi, Junki Mizusawa, Norio Saito, Yukihide Kanemitsu, Nobuhiro Takiguchi, Masayuki Ohue, Takeshi Kato, Yasumasa Takii, Toshihiko Sato, Naohiro Tomita, Shigeki Yamaguchi, Makoto Akaike, Hideyuki Mishima, Yoshiro Kubo, Kenichi Nakamura, Haruhiko Fukuda, Yoshihiro Moriya, Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205. European Journal of Cancer. ,vol. 50, pp. 2231- 2240 ,(2014) , 10.1016/J.EJCA.2014.05.025

R. Labianca, B. Nordlinger, G.D. Beretta, S. Mosconi, M. Mandalà, A. Cervantes, D. Arnold, Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology. ,vol. 31, pp. 1291- 1305 ,(2013) , 10.1093/ANNONC/MDT354